Vaccine Market
One of the big advantages of Merck's MMRV vaccine was that it combined four childhood jabs into one. But new evidence that the shot increases the risk of febrile seizures in infants led to a new recommendation from the CDC that physicians deliver the vaccine in two steps rather than one. Story
The rate of genital wart infections has plunged in Australia, the result of a mass HPV vaccination program. Story
Vaccine Research
A new primate study indicates that people exposed to the lethal Marburg virus may be protected by a vaccination a day or two after exposure. Story
Novavax named Gregory Glenn, M.D., as the company's chief scientific officer. Glenn is credited with providing "the scientific and technical leadership that led to the acquisition of IOMAI by Intercell in 2008." He has co-authored more than 150 research publications, scientific abstracts and presentations, and successful grant applications. Release
Researchers in Australia are putting a new nasal drop vaccine through trials for respiratory syncytial virus (RSV) and the parainfluenza virus type 3 (PIV3) in infants and toddlers. Story
The cancer vaccine developer Oncothyreon has gained commitments for up to $20 million in fresh financing. Report
James Connolly has been named president and CEO of the Aeras Global TB Vaccine Foundation. Release
Crucell and Sanofi Pasteur have restructured their agreement on vaccine development. Release